WO1999037275A2

WO1999037275A2 - COSMETIC OR PHARMACEUTICAL PREPARATIONS WITH A LESS STICKY FEEL, CONTAINING GLYCERIN ESTERS OF α-HYDROXY CARBOXYLIC ACIDS AND SATURED FATTY ACIDS

Info

Publication number: WO1999037275A2
Application number: PCT/EP1999/000056
Authority: WO
Inventors: Gerhard Benner; Stephanie Von Der Fecht; Jens Nielsen; Sabine Schulz
Original assignee: Beiersdorf Ag
Priority date: 1998-01-22
Filing date: 1999-01-07
Publication date: 1999-07-29
Also published as: JP2002501010A; DE19802204A1; EP1049453A2; WO1999037275A3

Abstract

Cosmetic or pharmaceutical preparations characterised by the following features: they contain (I) one or several partially neutralised esters of monoglycerides and or di-glycerides of saturated fatty acids with citric acid, (II) one or several fatty alcohols selected from the group of branched and unbranched alkyl alcohols with 12-40 carbon atoms, (III) they are prepared as O/W emulsions.

Description

description

Cosmetic or pharmaceutical preparations with reduced stickiness. containing glycerol esters of α-hydroxycarboxylic acids and saturated fatty acids

The present invention relates to cosmetic or pharmaceutical preparations with a reduced feeling of stickiness, to processes for their preparation and to the use of active ingredients for reducing the feeling of stickiness of cosmetic preparations.

Cosmetic skin care is primarily to be understood as meaning that the natural function of the skin as a barrier against environmental influences (e.g. dirt, chemicals, microorganisms) and against the loss of the body's own substances (e.g. water, natural fats, electrolytes) is strengthened or restored.

If this function is disturbed, there may be an increased absorption of toxic or allergenic substances or an infestation of microorganisms and, as a result, toxic or allergic skin reactions.

The aim of skin care is also to compensate for the loss of fat and water in the skin caused by daily washing. This is especially important when the natural regeneration ability is insufficient. In addition, skin care products are intended to protect against environmental influences, especially sun and wind, and to delay skin aging.

Medical compositions usually contain one or more drugs in effective concentration. For the sake of simplicity, a clear distinction is made between cosmetic and medical use and corresponding pro products refer to the legal provisions of the Federal Republic of Germany (e.g. cosmetics regulation, food and drug law).

Common manifestations of cosmetic or dermatological preparations are finely dispersed multiphase systems in which one or more fat or oil phases are present in addition to one or more water phases. Of these systems, the actual emulsions are the most widespread.

Preparations for cosmetic or therapeutic skin care in particular contain mixtures of oils or oil-soluble substances and water or water-soluble substances as essential components. Certain components of the water phase, e.g. Glycerin, but also the oil phase, e.g. tocopheryl acetate, have a negative effect on the sensory properties of the preparations in higher concentrations. This often manifests itself in an increased feeling of stickiness or a feeling of greasiness when using corresponding preparations, which in individual cases may not be marketable because they are not accepted by the consumer or judged negatively.

It is known to reduce this feeling of stickiness or also of feeling of lubrication by adding certain substances, for example some selected powder raw materials, in particular talc. Apart from the fact that this is rarely completely successful, such an addition also changes the viscosity of the product in question and reduces the stability.

The task was therefore to remedy all of these disadvantages of the prior art. In particular, products with reduced stickiness or greasiness should be made available. Products in the fields of care cosmetics, decorative cosmetics and pharmacological galenics should equally be freed from the disadvantages of the prior art described.

Furthermore, it was an object of the invention to develop cosmetic bases for cosmetic preparations which are notable for good skin tolerance.

Another object of the present invention was to provide products with the widest possible range of applications. For example, basics for

Forms of preparation such as cleaning emulsions, face and body care preparations gene, but also very medicinal-pharmaceutical dosage forms are created, for example preparations against acne and other skin symptoms.

Surprisingly, all of these tasks are solved by cosmetic or pharmaceutical preparations, characterized by the following features: they contain

(I) one or more partially neutralized esters of monoglycerides and / or diglycerides of saturated fatty acids with citric acid, (II) one or more fatty alcohols selected from the group of branched and unbranched alkyl alcohols with 12 to 40 carbon atoms (III) they are O / W- Emulsions.

According to the invention is also the use of combinations of (I) one or more partially neutralized esters of monoglycerides and / or diglycerides of saturated fatty acids with citric acid, and

(II) one or more fatty alcohols, chosen from the group of branched and unbranched alkyl alcohols having 12 to 40 carbon atoms, for the manufacture of non-sticky O / W emulsions and the use of such combinations to reduce the Klebrigke ^'rt O / W Emulsions.

A particularly advantageous citric acid ester is glyceryl stearate citrate. Such citric acid esters are available, for example, under the product name "IMWITOR® 370" from Hüls AG.

The total amount of one or more partially neutralized esters of monoglycerides and / or diglycerides of saturated fatty acids with citric acid in the finished cosmetic or dermatological preparations is advantageously in the range from 0.1 to 10.0% by weight, preferably 0.5 to 6 , 0% by weight, based on the total weight of the preparations.

The preferred fatty alcohol used according to the invention is cetyl-stearyl alcohol (a mixture of hexadecanol-1 and octadecanol-1 in approximately equal proportions). The total amount of one or more fatty alcohols used according to the invention in the finished cosmetic or dermatological preparations is advantageously selected from the range from 0.1 to 10.0% by weight, preferably 0.5 to 6.0% by weight, based on the total weight of the preparations.

It is advantageous according to the invention to choose weight ratios of glycerol esters of α-hydroxycarboxylic acids and saturated fatty acids on the one hand and fatty alcohols on the other hand from 7: 3 to 3: 7, preferably from 2: 1 to 1: 2, particularly preferably from about 1: 1.

According to the invention, it is possible and advantageous to freely choose the proportion of the oil phase of the preparations according to the invention in the range from 5 to 40% by weight, based on the total weight of the preparations.

The following can be used as basic components of the preparations according to the invention:

Water or aqueous solutions

Oils, such as triglycerides of capric or caprylic acid, but preferably castor oil; - Fats, waxes and other natural and synthetic fat bodies, preferably

Esters of fatty acids with low C alcohols, e.g. with isopropanol, propylene glycol or glycerin, or esters of fatty alcohols with low C number alkanoic acids or with fatty acids; Alcohols, diols or polyols of low C number, and their ethers, preferably ethanol, isopropanol, propylene glycol, glycerin, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and similar products .

Mixtures of the abovementioned solvents are used in particular. Water can also be a component of alcoholic solvents.

The oil phase of the emulsions in the sense of the present invention is advantageously selected from the group of esters from saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 carbon atoms, from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 C atoms. Such ester oils can then advantageously be selected from the group of isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononylisononanoate, 2-ethyl-2-ethylhexyl-ethylhexyl-ethyl-hexyl-ethyl-hexyl-ethyl-acrylate 2-octyldodecyl palmitate, oleyl oleate, olerlerucate, erucyl oleate, erucyl erucate as well as synthetic, semisynthetic and natural mixtures of such esters, for example jojoba oil.

Furthermore, the oil phase can advantageously be chosen from the group of branched and unbranched hydrocarbons and waxes, the silicone oils, the dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols, and also the fatty acid triglycerides, especially the triglycerol esters, saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12 - 18 carbon atoms. The fatty acid triglycerides can, for example, advantageously be selected from the group of synthetic, semisynthetic and natural oils, e.g. Olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil and the like.

Any mixtures of such oil and wax components can also be used advantageously for the purposes of the present invention. It may also be advantageous to use waxes, for example cetyl palmitate, as the sole lipid component of the oil phase.

The oil phase is advantageously selected from the group consisting of 2-ethylhexyl isostearate, octyldodecanol, isotridecyl isononanoate, isoeicosane, 2-ethylhexyl cocoate, C ₁₂ -is alkylbenzoate, caprylic capric acid triglyceride, dicaprylyl ether.

Mixtures of C 1 -alkylbenzoate and 2-ethylhexyl isostate, mixtures of C ₂ -alkybenzoate and isotridecyl isononanoate and mixtures of C ₂ -i ₅ alkylbenzoate, 2-ethylhexyl isostearate and isotridecyl isononanoate are particularly advantageous. Of the hydrocarbons, paraffin oil, squalane and squalene can be used advantageously for the purposes of the present invention.

The oil phase can advantageously also have a content of cyclic or linear silicone oils or consist entirely of such oils, although it is preferred to use an additional content of other oil phase components in addition to the silicone oil or the silicone oils.

Cyclomethicone (octamethylcyclotetrasiloxane) is advantageously used as the silicone oil to be used according to the invention. However, other silicone oils can also be used advantageously for the purposes of the present invention, for example hexamethylcyclotrisiloxane, polydimethylsiloxane, poly (methylphenylsiloxane).

Mixtures of cyclomethicone and isotridecyl isononanoate, of cyclomethicone and 2-ethylhexyl isostearate are also particularly advantageous.

Emulsions according to the invention in the sense of the present invention, e.g. in the form of a skin protection cream, a skin lotion, a cosmetic milk, for example in the form of a sun protection cream or a sun protection milk, are advantageous and contain e.g. Fats, oils, waxes and / or other fat bodies, as well as water and one or more emulsifiers, as are usually used for such a type of formulation.

It is of course known to the person skilled in the art that sophisticated cosmetic compositions are usually inconceivable without the customary auxiliaries and additives. These include, for example, consistency agents, fillers, perfumes, dyes, emulsifiers, additional active ingredients such as vitamins or proteins, light stabilizers, stabilizers, insect repellents, alcohol, water, salts, antimicrobial, proteolytic or keratolytically active substances, etc.

Mutatis mutandis, corresponding requirements apply to the formulation of medical preparations.

Medical topical compositions in the sense of the present invention generally contain one or more drugs in effective concentration. The For the sake of simplicity, reference is made to the legal provisions of the Federal Republic of Germany for a clear distinction between cosmetic and medical use and corresponding products (e.g. cosmetics regulation, food and drug law).

It is also advantageous to add the combinations of glycerol esters of α-hydroxycarboxylic acids and saturated fatty acids on the one hand and fatty alcohols on the other hand as an additive to preparations which already contain other active ingredients for other purposes.

Accordingly, cosmetic or topical dermatological compositions in the sense of the present invention, depending on their structure, can be used, for example, as skin protection cream, cleansing milk, sunscreen lotion, nutritional cream, day or night cream, etc. It is possibly possible and advantageous to use the compositions according to the invention as a basis to use for pharmaceutical formulations.

Cosmetic and dermatological preparations which are in the form of a sunscreen are also favorable. In addition to the active ingredient used according to the invention, these preferably additionally contain at least one UVA filter substance and / or at least one UVB filter substance and / or at least one inorganic pigment.

However, it is also advantageous in the sense of the present inventions to create such cosmetic and dermatological preparations, the main purpose of which is not protection against sunlight, but which nevertheless contain UV protection substances. For example, UV-A or UV-B filter substances are usually incorporated into day creams.

Preparations according to the invention can advantageously contain substances which absorb UV radiation in the UVB range, the total amount of the filter substances being, for example, 0.1% by weight to 30% by weight, preferably 0.5 to 10% by weight, in particular 1 is up to 6 wt .-%, based on the total weight of the preparations. The UVB filters can be oil-soluble or water-soluble. Examples of oil-soluble substances are:

3-benzylidene camphor and its derivatives, e.g. 3- (4-methylbenzylidene) camphor,

4-aminobenzoic acid derivatives, preferably 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester, 4- (dimethylamino) benzoic acid amyl ester;

Esters of cinnamic acid, preferably 4-methoxycinnamic acid (2-ethylhexyl) ester, 4-methoxycinnamic acid isopentyl ester;

Esters of salicylic acid, preferably salicylic acid (2-ethylhexyl) ester, salicylic acid

(4-isopropylbenzyl) ester, salicylic acid homomethyl ester; Derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-

Hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;

Esters of benzalmalonic acid, preferably di-2-ethylhexyl 4-methoxybenzalma! One; - 2,4,6-trianilino- (p-carbo-2'-ethyl-1'-hexyloxy) -1, 3,5-triazine

The following are advantageous as water-soluble substances:

2-phenylbenzimidazole-5-sulfonic acid and its salts, e.g. Sodium, potassium or triethanolammonium salts, sulfonic acid derivatives of benzophenones, preferably 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its salts;

Sulfonic acid derivatives of 3-benzylidene camphor, e.g. 4- (2-oxo-3-bornylidene-methyl) benzenesulfonic acid, 2-methyl-5- (2-oxo-3-bornylidene-methyl) sulfonic acid and their salts.

The list of UVB filters mentioned, which can be used according to the invention, is of course not intended to be limiting.

It can also be advantageous to use UVA filters in preparations according to the invention which are usually contained in cosmetic and / or dermatological preparations. Such filter substances are preferably derivatives of dibenzoylmethane, in particular 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1, 3-dione and 1-phenyl-3- ( 4'-isopropylphenyl) propane-1,3-dione. Preparations containing these combinations are also the subject of the invention. It can the same amounts of UVA filter substances that were mentioned for UVB filter substances are used.

Cosmetic and / or dermatological preparations in the sense of the present invention can also contain inorganic pigments which are usually used in cosmetics to protect the skin from UV rays. These are oxides of titanium, zinc, iron, zirconium, silicon, manganese, aluminum, cerium and mixtures thereof, as well as modifications in which the oxides are the active agents. It is particularly preferred to use pigments based on titanium dioxide. The amounts given for the above combinations can be used.

The cosmetic and dermatological preparations according to the invention can contain cosmetic active ingredients, auxiliaries and / or additives, as are usually used in such preparations, e.g. Antioxidants, preservatives, bactericides, perfumes, anti-foaming substances, dyes, pigments that have a coloring effect, thickeners, surface-active substances, emulsifiers, softening, moisturizing and / or moisturizing substances, fats, oils, waxes or other common components of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.

For the purposes of the present invention, it is advantageous to add further anti-irritant or anti-inflammatory active substances, in particular batyl alcohol (α-octadecylglyceryl ether), selachyl alcohol (α-9-octadecenylglyceryl ether), chimyl alcohol (α-hexadecylglyceryl ether), bisabolol and / or panthenol.

It is also advantageous to add customary antioxidants to the preparations for the purposes of the present invention. According to the invention, all the antioxidants suitable or customary for cosmetic and / or dermatological applications can be used as favorable antioxidants.

The antioxidants are advantageously selected from the group consisting of amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocaninic acid) and their derivatives, peptides such as D, L-camosine, D-carnosine, L- Carnosine and their derivatives (eg anserine), carotenoids, carotenes (eg α-carotene, β-carotene, ψ-lycopin) and their derivatives, chlorogenic acid and their derivatives, lipoic acid and their derivatives (eg dihydroliponic acid), aurothioglucose, propylthiouracil and other thiols (e.g. thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, γ-linoleyl, Cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (e.g. buthioninsulfoximines, homocysteine sulfoximine, homocysteine sulfoximine, , Hexa-, Heptathioninsulfoximin) in very low tolerable doses (e.g. pmol to μmol / kg), also (metal) chelators (e.g. α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), α-hydroxy acids (e.g. citric acid, lactic acid, apple) oleic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g. γ-linolenic acid, linoleic acid, oleic acid), folic acid and their derivatives, furfurylidene sorbitol and its derivatives, ubiquinone and ubiquinol and their derivatives, vitamin C and derivatives (e.g. ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) as well as coniferyl benzoate of benzoin, rutinic acid and their derivatives , α-glycosyl rutin, ferulic acid, furfurylidene glucitol, carnosine, butylated hydroxytoluene, butylated hydroxyanisole, nordihydroguajak resin acid, nordihydroguajaretic acid, trihydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, eg zinc and its derivatives (zinc and its derivatives) and its derivatives (zinc and its derivatives) and its derivatives (zinc and its derivatives and its derivatives, such as zinc and its derivatives and zinc and its derivatives and its derivatives, such as zinc and derivatives) eg selenomethionine), stilbenes and their derivatives (eg stilbene oxide, trans-stilbene oxide) and the D suitable according to the invention Derivatives (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these active ingredients.

The amount of the antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 1 to 10% by weight, based on the total weight of the preparation .

If vitamin E and / or its derivatives represent the antioxidant (s), it is advantageous to choose their respective concentrations from the range of 0.001-10% by weight, based on the total weight of the formulation. Suitable blowing agents for cosmetic and / or dermatological preparations which can be sprayed from aerosol containers for the purposes of the present invention are the customarily known volatile, liquefied blowing agents, for example hydrocarbons (propane, butane, isobutane), which can be used alone or as a mixture with one another. Compressed air can also be used advantageously.

Of course, the person skilled in the art knows that there are non-toxic propellant gases per se which would in principle be suitable for the implementation of the present invention in the form of aerosol preparations, but which should nevertheless be dispensed with because of their harmful effects on the environment or other associated circumstances, in particular fluorocarbons and chlorofluorocarbons ( CFCs).

Are the cosmetic or dermatological preparations in the sense of the present invention in the form of a lotion which is rinsed out and e.g. before or after decolorization, before or after shampooing, between two shampooing steps, before or after permanent wave treatment, these are e.g. to aqueous or aqueous-alcoholic solutions, which may contain surface-active substances, preferably non-ionic or cationic surface-active substances, the concentration of which can be between 0.1 and 10% by weight, preferably between 0.2 and 5% by weight . These cosmetic and / or dermatological preparations can also be aerosols with the auxiliaries usually used for them.

A cosmetic preparation in the form of a lotion in the sense of the present invention, which is not rinsed out, in particular a lotion for inlaying the hair, a lotion used for blow-drying the hair, a styling and treatment lotion, generally provides an aqueous one , alcoholic or aqueous-alcoholic solution and contains at least one cationic, anionic, non-ionic or amphoteric polymer or mixtures thereof, as well as the active ingredient combinations according to the invention. The amount of the polymers used is e.g. between 0.1 and 10% by weight, preferably between 0.1 and 3% by weight.

Cosmetic preparations in the sense of the present invention for the treatment and

Care of the hair which contains the active ingredient used according to the invention can be present as emulsions which are of the non-ionic or anionic type. Non-ionic In addition to water, emulsions contain oils or fatty alcohols, which can also be polyethoxylated or polypropoxylated, for example, or mixtures of the two organic components. These emulsions may contain cationic surface-active substances.

Cosmetic preparations in the sense of the present invention for the treatment and care of the hair can be in the form of gels which, in addition to an effective content of the active compound according to the invention and solvents usually used for this, preferably water, or organic thickeners, e.g. Gum arabic, xanthan gum, sodium alginate, cellulose derivatives, preferably methyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose or inorganic thickeners, eg. B. aluminum silicates such as bentonite, or a mixture of polyethylene glycol and polyethylene glycol stearate or distearate. The thickener is in the gel e.g. in an amount between 0.1 and 30% by weight, preferably between 0.5 and 15% by weight.

The following examples are intended to illustrate the present invention.

example 1

% By weight

Paraffin oil 5.00

Ethanol 3.00

Glycerin 3.00

Glyceryl stearate citrate 2.00

Cetylstearyl alcohol 2.00

Dimethicone 1.00

Carbomer 0.10

Wool wax alcohol 0.10

Tocopheryl acetate 0.10

Dyes, perfume, preservatives q.s.

Water ad 100.00

Example 2

% By weight

Paraffin oil 40.00

Ethanol 3.00

Glycerin 3.00

Glyceryl stearate citrate 2.00

Cetylstearyl alcohol 2.00

Dimethicone 1.00

Carbomer 0.10

Wool wax alcohol 0.10

Tocopheryl acetate 0.10

Dyes, perfume, preservatives q.s.

Water ad 100.00 Example 3

% By weight

Wool wax alcohol 0.10

Glyceryl stearate citrate 2.00

Paraffin oil 9.00

Cetylstearyl alcohol 2.00

Carbomer 0.10

Dimethicone 1.00

Glycerin 3.00

Ethanol 3.00

Tocopheryl acetate 0.10

Dyes, perfume, preservatives q.s.

Water ad 100.00

Example 4

% By weight

Wool wax alcohol 0.10

Glyceryl stearate citrate 2.00

Paraffin oil 14.00

Cetylstearyl alcohol 2.00

Carbomer 0.10

Dimethicone 1.00

Glycerin 3.00

Ethanol 3.00

Tocopheryl acetate 0.10

Dyes, perfume, preservatives q.s.

Water ad 100.00 Example 5

% By weight

Wool wax alcohol 0.10

Glyceryl stearate citrate 2.00

Paraffin oil 19.00

Cetylstearyl alcohol 2.00

Carbomer 0.10

Dimethicone 1.00

Glycerin 3.00

Ethanol 3.00

Tocopheryl acetate 0.10

Dyes, perfume, preservatives q.s.

Water ad 100.00

Example 6

% By weight

Wool wax alcohol 0.10

Glyceryl stearate citrate 2.00

Paraffin oil 24.00

Cetylstearyl alcohol 2.00

Carbomer 0.10

Dimethicone 1.00

Glycerin 3.00

Ethanol 3.00

Tocopheryl acetate 0.10

Dyes, perfume, preservatives q.s.

Water ad 100.00 Example 7

% By weight

Ethanol 3 00

Glycerin 3.00

Isohexadecane 2.00

Caprylic / Capric Triglyceride 2.00

Paraffin oil 2.00

Glyceryl stearate citrate 1 80

Cetylstearylalcohol 1, 80

Dimethicon 1, oo

Carbomer 0.10

Wool wax alcohol 0.10

Tocopheryl acetate 0.10

Dyes, perfume, preservatives q.s. Water ad 100.00

Example 8

% By weight

Glycerin 5.00

Caprylic / Capric Triglyceride 5.00

Ethanol 3.00

Paraffin oil 3.00

Microcrystalline wax, paraffin oil 3.00

Cyclomethicone 2.00

Dimethicone 2.00

Octyldodecanol 2.00

Glyceryl stearate citrate 1 80

Cetylstearylalcohol 1, 80

Carbomer 0.20

Wool wax alcohol 0.10

Bisabolol 0.10

Dyes, perfume, preservatives qs water ad 100.00 Example 9

% By weight

Caprylic / Capric Triglyceride 3.50

Glycerin 3.00

Glyceryl stearate citrate 2.40

Cetylstearyl alcohol 2.40

Isohexadecane 2.00

Paraffin oil 2.00

Octyl methoxycinnamate 1.30

Aluminum Starch Octenyl Suceinate 1, 00

Dimethicone 1.00

Glycyrrhiza glabra extract 0.50

NaEDTA 0.50

Butyl methoxydibenzoyl methane 0.40

Carbomer 0.20

Wool wax alcohol 0.10

Tocopheryl acetate 0.10

Dyes, perfume, preservatives q.s. Water ad 100.00

Claims

claims

1. Cosmetic or pharmaceutical preparations, characterized by the following features: They contain

(I) one or more partially neutralized esters of monoglycerides and / or diglycerides of saturated fatty acids with citric acid and

(II) one or more fatty alcohols selected from the group of branched and unbranched alkyl alcohols with 12 to 40 carbon atoms (III) they are O / W emulsions.

2. Use of combinations

(II) one or more fatty alcohols, selected from the group of branched and unbranched alkyl alcohols having 12 to 40 carbon atoms, for producing non-tacky OΛΛ emulsions or for reducing the stickiness of O W emulsions.

3. Preparations according to claim 1 or use according to claim 2, characterized in that the glyceryl stearate citrate is chosen as partially neutralized ester of monoglycerides and / or diglycerides of saturated fatty acids with citric acid.

4. Preparations according to claim 1 or use according to claim 2, characterized in that the cetyl-stearyl alcohol is chosen as the fatty alcohol.

5. Preparations according to claim 1 or use according to claim 2, characterized in that the total amount of one or more partially neutralized esters of monoglycerides and / or diglycerides of saturated fatty acids with citric acid in the preparations is selected from the range 0.1-10, 0% by weight, preferably 0.5-6.0% by weight, based on the total weight of the preparations.

6. Preparations according to claim 1 or use according to claim 2, characterized in that the total amount of one or more fatty alcohols in the fer- term cosmetic or dermatological preparations is selected from the range of 0.1-10.0% by weight, preferably 0.5-6.0% by weight, based on the total weight of the preparations.

7. Preparations according to claim 1 or use according to claim 2, characterized in that weight ratios of partially neutralized esters of monoglycerides and / or diglycerides of saturated fatty acids with citric acid on the one hand and fatty alcohols on the other hand are selected from the range from 7: 3 to 3: 7, preferably from 2: 1 to 1: 2, particularly preferably from about 1: 1.

8. Preparations according to claim 1 or use according to claim 2, characterized in that the proportion of the oil phase of the preparations according to the invention in the range of 5 to 40 wt .-%, based on the total weight of the preparations, is selected.